Japanese drugmaker Astellas Pharma says it has submitted a New Drug Application (NDA) to Japan’s Ministry of Health, Labor ...

Astellas Pharma seeks Japanese conditional approval of avacincaptad pegol intravitreal solution to treat geographic atrophy: Tokyo Thursday, February 6, 2025, 09:00 Hrs [IST] Aste ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.JzBkOQ-g.js ...

Ministry of Health, Labour and Welfare to evaluate ACP as potential first and only treatment for patients with geographic atrophy (GA) secondary ...

(RTTNews) - Astellas Pharma Inc. (ALPMY) Wednesday announced the submission of a New Drug Application or NDA in Japan for Conditional Approval of Avacincaptad Pegol intravitreal solution or ACP for ...

Given the promising development and potential application of aptasensors, future research studies made will witness the great practicality of using aptamer-based biosensors within the field of food ...

Lastly, the identified aptamer sequences were also effective in recognition of fusion proteins, which greatly expands the scope of potential applications of such aptamers. This work suggested that the ...

Researchers at the University of Toronto have invented a new method that uses DNA sequencing to measure metabolites. This ...

After hours: February 3 at 6:25:32 PM EST ...

This learning intervention is a full qualification which consists of structured unit standard-based learning combined with practical/workplace experience which totals to 147 credits. After having gone ...

Create your best work on all your devices—from desktop to web—using the tools you need for home and business.